Intestinal Neoplasms
Information
- Disease name
- Intestinal Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05551052 | Active, not recruiting | CRC Detection Reliable Assessment With Blood | September 8, 2022 | July 2024 | |
| NCT06260150 | Active, not recruiting | N/A | Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients. | April 1, 2023 | April 2024 |
| NCT04673136 | Completed | N/A | Usefulness of GI-GENIUS in FIT-based Colorectal Cancer Screening Program. | April 1, 2021 | March 31, 2022 |
| NCT01996306 | Completed | Phase 3 | A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC | December 2, 2013 | June 30, 2018 |
| NCT02785783 | Completed | N/A | Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection | May 13, 2016 | August 7, 2018 |
| NCT03559543 | Completed | Phase 2 | Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma | October 25, 2018 | January 15, 2024 |
| NCT03037385 | Completed | Phase 1/Phase 2 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | March 17, 2017 | March 21, 2024 |
| NCT04080843 | Completed | Phase 2 | Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | November 15, 2019 | July 1, 2022 |
| NCT04744688 | Completed | Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment | April 6, 2021 | May 27, 2024 | |
| NCT03072472 | Completed | N/A | BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities | February 14, 2017 | February 13, 2018 |
| NCT06048146 | Enrolling by invitation | N/A | A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis | October 1, 2022 | September 1, 2029 |
| NCT05193292 | Not yet recruiting | Phase 2 | Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer | January 2022 | January 2025 |
| NCT03280407 | Recruiting | Phase 2 | NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer | March 1, 2017 | December 31, 2024 |
| NCT04949282 | Recruiting | Spanish Series of Patients Treated With the Radionuclide Lutetium177 | May 10, 2021 | December 31, 2035 | |
| NCT04755920 | Recruiting | Phase 2 | SGM-101 in Colorectal Brain Metastases. | January 1, 2024 | February 2026 |
| NCT04644315 | Terminated | Phase 2 | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | May 24, 2021 | May 16, 2022 |
| NCT03659357 | Unknown status | Study of Small Bowel Tumor With Dual-phase Enhanced Computed Tomography (CTE) and Magnetic Resonance Enterography (MRE) | September 1, 2018 | September 30, 2021 | |
| NCT01995942 | Unknown status | Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial | June 7, 2013 | February 2, 2022 | |
| NCT02005965 | Unknown status | Low Rectal Cancer Study (MERCURY II) | August 13, 2007 | March 11, 2021 | |
| NCT02202928 | Unknown status | Phase 2 | Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer | July 2014 | December 2017 |
| NCT03271255 | Unknown status | Phase 2 | Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) | May 23, 2018 | December 31, 2022 |
| NCT03303495 | Unknown status | Phase 3 | A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC | November 14, 2011 | December 31, 2018 |
| NCT01037049 | Unknown status | Phase 2 | Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks | October 16, 2009 | December 8, 2019 |
| NCT05322486 | Unknown status | Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | October 29, 2020 | December 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D007414